Business
HEALWELL Provides Corporate Update Including Improved Performance in AI Business, Acquisition of Remaining Interest in Pentavere and Deeper Integration within the AI Business Segment
HEALWELL announced improved performance for its core AI business segment with preliminary revenue...
About this update from Healwell Ai Inc. Class A
[{"type":"text","content":"HEALWELL Provides Corporate Update Including Improved Performance in AI Business, Acquisition of Remaining Interest in Pentavere and Deeper Integration within the AI Business SegmentHEALWELL announced improved performance for its core AI business segment with preliminary revenues expected to exceed $5 million for the first six months of 2025, reflecting a year-over-year increase of over 200% as compared to the same period last year. This strong performance is expected to lead to positive Adjusted EBITDA for the AI business segment during the first six months of the year.HEALWELL acquires remaining 49% of Pentavere Research Group Inc., by exercising a call option to gain full ownership of the business. Pentavere is an award winning and globally renowned AI healthcare company which is responsible for the development of a leading AI-driven patient identification platform, DARWEN.TMWith 100% ownership of Pentavere, HEALWELL intends to deepen integration between its AI businesses and accelerate commercialization of AI products across healthcare offerings. Toronto, Ontario--(Newsfile Corp. - July 16, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (\"HEALWELL\" or the \"Company\"), a healthcare artificial intelligence company focused on preventative care, is pleased to provide a corporate update, including improved performance in its AI business units, the acquisition of the remaining interest in Pentavere Research Group Inc. (\"Pentavere\") and deeper integration of the entities within its AI business segment. The Company's AI business segment, encompassing Pentavere, Khure Health (\"Khure\"), and Mutuo Health Solutions (\"Mutuo\") businesses, is on track to exceed $5 million in revenues for the first six months of 2025, ending June 30, 2025, representing a year-over-year increase of over 200%. This strong performance is expected to lead to positive Adjusted EBITDA for the AI business segment during the same period.Strategic Acquisition and Performance HighlightsFull Ownership of Pentavere: HEALWELL has exercised its call option to acquire the remaining 49% of Pentavere, gaining full ownership of the globally recognized AI healthcare company. Pentavere is the developer of DARWEN™, a leading AI-driven patient identification platform crucial for preventative care. Robust Organic Growth: Preliminary results for Q2-2...